A new drug could revolutionize the fight against breast cancer.
Experts are working on a new study in Boston to find out if taking baby aspirin could reduce the risk of breast cancer recurrence in women undergoing treatment.
Dr. Andrew Salner, of Hartford Hospital’s Helen and Harry Gray Cancer Center, said the study is promising.
“We've actually known for several years that taking baby aspirin may reduce the risk of certain stomach, esophageal and colon cancer,” Salner said.
Experts aren’t sure why this is the case, but they do have a few theories.
Aspirin is typically taken to reduce swelling.
“Inflammation may be one of the mediators for cancer cells to grow and spread. And if you can slow the inflammation process down you may be able to stop the cancer cells,” Salner said.
Aspirin also interferes with platelets, which are the cells in blood that help with clotting.
Salner said cancer patients may clot more than normal, and this may help stop the cancer cells from growing.
“Other than the bleeding risk from cancer in the stomach, it's a pretty safe drug to take. And if it can lower cancer recurrence, that would be a wonderful thing,” Salner said.
If the study proves to be true, the treatment is affordable and would be available worldwide.
The study is still in the beginning stages and is expected to take another five years.
Copyright 2015 WFSB (Meredith Corporation). All rights reserved.